Tag: position

NORTH BERGEN, NJ, July 16, 2025 (GLOBE NEWSWIRE) -- Free Flow, Inc. (OTC PK: FFLO), which is incorporated in the state of Delaware as Free Flow USA, Inc., today announced that the Company’s Accurate Investments, Inc subsidiary has entered into a contract to purchase a real estate investment property in New Jersey with existing and arranged highly-accredited tenants that would pay an approximate triple net lease amount of over $1,800,000 per annum against long term leases.

FORM 8.3

WARSCHAU, Polen, July 16, 2025 (GLOBE NEWSWIRE) -- Polen tritt in die operative Phase der Offshore-Erschließung ein – die ersten Turbinen stehen bereits in der Ostsee, und bis 2026 wird Strom aus Offshore-Quellen in polnische Haushalte fließen. Dies ist ein entscheidender Moment – Polen entwickelt sich rasch zu einem der vielversprechendsten Märkte Europas in Bezug auf Investitionen, Partnerschaften und Innovation. Jetzt ist der beste Zeitpunkt, um in Polen zu investieren und sich dort zu positionieren – dies wird das Hauptthema der Konferenz „Offshore Wind Poland 2025” sein, die vom Polnischen Windenergieverband (Polish Wind Energy Association) organisiert wird.

VARSOVIE, Pologne, 16 juill. 2025 (GLOBE NEWSWIRE) -- La Pologne inaugure la phase opérationnelle de son développement offshore. Les premières turbines sont désormais installées en mer Baltique, et l’électricité issue de sources marines alimentera les foyers du pays dès 2026. Voilà bien un tournant décisif, la Pologne se plaçant rapidement parmi les marchés les plus prometteurs d’Europe en matière d’investissements, de partenariats et d’innovation. C’est le moment idéal pour investir et s’implanter en Pologne et tel sera le thème central de la conférence Offshore Wind Poland 2025, organisée par l’Association polonaise de l’énergie éolienne (PWEA).

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.

Jackbit announces new casino welcome offer with 100 free spins and no wagering requirements. Read how it unfolds for casino players in 2025. 

FORM 8.5 (EPT/RI)

FORM 8.3